Search for Ranbaxy Laboratories Ltd and
  1. April 7, 2014

    Daiichi / Ranbaxy: race for the exit

    When Daiichi Sankyo bought its majority stake in Ranbaxy, investors cheered it with a 5 per cent share price rally. They...

  2. April 7, 2014

    India’s Sun Pharma offers $3.2bn for ailing Ranbaxy

    Sun Pharmaceutical Industries has agreed to pay $3.2bn for the equity in Ranbaxy, the Indian generic drugmaker that has...

  1. February 2, 2014

    Ranbaxy in need of further treatment

    Arun Sawhney wanted to be clear. “Ranbaxy is a different company today”, the chief executive of the Indian drugs group said...

  2. January 24, 2014

    Ranbaxy shares sink on US FDA product ban

    Shares in Ranbaxy, the troubled Indian pharmaceutical company, plunged 20 per cent after the US banned imports from a fourth...

  3. September 16, 2013

    Ranbaxy Laboratories: pills & spills

    Something is very wrong at Ranbaxy Laboratories. The Indian generic drugmaker’s shares fell 30 per cent on Monday after the...

  4. September 4, 2013

    India approves $1.6bn acquisition of Agila Specialties by Mylan

    India’s government has given the go-ahead for US-based pharmaceutical company Mylan’s long-stalled $1.6bn acquisition of...

  5. June 19, 2013

    Lundbeck fined €94m for ‘pay for delay’ deals to rivals

    European regulators have fined Lundbeck, the Danish pharmaceutical company, €94m for paying rivals to delay cut-price...

  6. beyondbrics

    May 23, 2013

    India's Ranbaxy: another can of worms

    Last week Ranbaxy Laboratories, India’s biggest pharmaceuticals company, must have thought it had at last settled an...

  7. beyondbrics

    May 14, 2013

    Ranbaxy pleads guilty and settles US felony but outlook remains unclear

    The US subsidiary of Ranbaxy Laboratories, India’s biggest pharmaceuticals group, has pleaded guilty to felony charges...

  8. April 3, 2013

    India benefits from Japan Inc shift

    As Indian finance minister Palaniappan Chidambaram wraps up an investment promotion trip to Tokyo on Wednesday, he has...

  9. beyondbrics

    February 27, 2013

    Ranbaxy: losses, again

    Shares in Indian generic drugs group Ranbaxy Laboratories dropped 4.2 per cent on Wednesday to Rs399.20, having lost 4 per...

  10. beyondbrics

    April 26, 2012

    Ranbaxy creates India's first new drug

    With the Wednesday launch of Synriam, an anti-malarial, Ranbaxy Laboratories became the first Indian pharmaceutical company...

  11. January 18, 2012

    Takeda to axe tenth of workforce in revamp

    Japanese drug company Takeda is to close sites and cut 2,800 jobs in Europe and North America – almost a tenth of its total...

  12. December 21, 2011

    Ranbaxy makes $500m provision on FDA deal

    Ranbaxy of India has set aside $500m to cover liabilities to settle potential claims in an extended legal dispute in the US,...

  13. December 21, 2011

    Daiichi Sankyo - bad medicine

    The directors of Daiichi Sankyo, Japan’s fourth-largest drugmaker, are not particularly wealthy men. Average total...

  14. December 5, 2011

    Pfizer tactics to combat generic drugmakers

    Controversial tactics that Pfizer is using to protect revenues of Lipitor, its top-selling cholesterol drug that lost patent...

  15. beyondbrics

    December 1, 2011

    Ranbaxy's relief after FDA approval

    Shares of India’s biggest pharmaceutical company, Ranbaxy Laboratories, opened up 10.4 per cent on Thursday, following news...

  16. beyondbrics

    November 30, 2011

    Ranbaxy's high blood pressure day

    Wednesday should have been a great day for India’s largest pharmaceutical company, Ranbaxy Laboratories. After all, it is...

  17. November 29, 2011

    Pfizer bids farewell to cholesterol drug rights

    Pfizer on Wednesday bids farewell to its exclusive rights to distribute Lipitor, the best selling drug in the pharmaceutical...

  18. beyondbrics

    October 10, 2011

    India's Religare: navigating the storms

    embed1 Religare Enterprises, the Indian financial services group, sees the global market turmoil as a potential opportunity...

  19. August 8, 2011

    Schincariol bid raises questions for Japan Inc

    Schincariol is not Japan Inc’s first brush with tough acquisitions. Three years before Kirin, the Japanese beer group,...

  20. June 27, 2011

    Japan: Drug companies seek growth fillip abroad

    Yasuchika Hasegawa, chief executive of Takeda, does not mince his words when he talks about domestic acquisitions. “We are...

  21. March 17, 2011

    Asia manufacturers yet to see quake impact

    Companies across Asia said they had so far seen little impact on the region’s complex manufacturing supply chain from the...

  22. March 2, 2011

    Daiichi Sankyo to buy US drugmaker

    Daiichi Sankyo has agreed to acquire a privately held US drugmaker for just under $1bn, the latest in a string of purchases...

  23. January 26, 2011

    Pharmaceuticals: Rich pickings at home and abroad

    International pharmaceutical companies once looked with frustration at Indian drug makers, which were notorious for churning...

  24. January 24, 2011

    The professional family business

    Wipro chairman Azim Premji The great family business is a powerful institution in India where about 95 per cent of all...

  25. January 5, 2011

    Innovation: Replicators no more

    The Pulpy fruit-based drink has been developed by Coca-Cola Pulpy may be an unfamiliar brand in London, New York or Tokyo....

  26. January 3, 2011

    India eyes drug industry ownership curbs

    An outcry over foreign takeovers of Indian pharmaceuticals companies has prompted the government to consider imposing limits...

  27. November 29, 2010

    Indian stocks recover after corruption probes

    Indian stocks halted their longest slide for six months as investors judged last week’s sell-off in the wake of the...

  28. November 19, 2010

    Scrutiny of Big Pharma set to intensify

    It may take many years to bring innovative medicines to market, but when things go wrong after launch with their production,...

  29. November 14, 2010

    Religare eyes emerging markets deals

    Religare Capital Markets, backed by the Indian billionaire Singh family, is planning acquisitions in four developing...

  30. August 23, 2010

    Challenges ahead for Sanofi chief

    Sanofi-Aventis has been cited as a possible buyer of Genzyme because of its long culture of dealmaking The French may...

  31. August 20, 2010

    Chinese pharma finds partner in India

    With a fast-growing and lucrative domestic market, most Chinese pharmaceutical companies have spurned the costs and...

  32. August 12, 2010

    Ranbaxy chief in unexpected departure

    India’s largest generics drugs producer, Ranbaxy Laboratories, on Thursday lost its second chief executive in little more...

  33. August 6, 2010

    Indian groups failing to plan for successor

    In a country where corporate leaders and politicians enjoy extraordinary professional longevity, lack of succession planning...

  34. July 26, 2010

    Khazanah trumps Fortis in Parkway battle

    Malaysia’s sovereign wealth fund Khazanah Nasional is set to take control of Parkway Holdings, Asia’s biggest listed...

  35. July 14, 2010

    Aids prognosis uncertain in New Delhi

    In 2006 Prashant Buradkar was bankrupt and close to death. The driver from the small Indian industrial town of Chandrapur...

  36. May 31, 2010

    Drugmakers realise FDA has learnt to bite

    If Johnson & Johnson underestimated long-simmering concerns about the manufacturing quality of leading drug brands including...

  37. May 27, 2010

    Sanofi receives interest in animal health assets

    Sanofi-Aventis, the French drugmaker, said on Thursday that it had received “significant interest” in its animal health...

  38. May 27, 2010

    Piramal to launch own drug 'by 2012'

    India's Piramal group plans to use part of the $3.7bn it received from the sale of its generic drugs unit to Abbott...

Search for Ranbaxy Laboratories Ltd and